Protocols
3 protocol(s) meet the specified criteria
Drug: XELODA
Protocol No.TitleStatus
EA2165-CIRBA Randomized Phase II Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal CancerOpen
ODO-TE-B301A Multinational, Multicenter, Randomized, Phase 3 Study of Tesetaxel plus a Reduced Dose of Capecitabine versus Capecitabine Alone in Patients with HER2 Negative, Hormone Receptor Positive, Locally Advanced or Metastatic Breast Cancer Previously Treated with a TaxaneOpen
ONT-380-206Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs. Placebo in Combination with Capecitabine and Trastuzumab in Patients with Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma (HER2CLIMB)Open